Isha Shah, MD | |
455 Toll Gate Rd, Warwick, RI 02886-2759 | |
(401) 681-2858 | |
(401) 921-6943 |
Full Name | Isha Shah |
---|---|
Gender | Female |
Speciality | Rheumatology |
Experience | 7 Years |
Location | 455 Toll Gate Rd, Warwick, Rhode Island |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1326490699 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RR0500X | Internal Medicine - Rheumatology | MD17764 (Rhode Island) | Primary |
207R00000X | Internal Medicine | LP03797 (Rhode Island) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Kent County Memorial Hospital | Warwick, RI | Hospital |
Women & Infants Hospital Of Rhode Island | Providence, RI | Hospital |
The Miriam Hospital | Providence, RI | Hospital |
South County Hospital Inc | Wakefield, RI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Affinity Physicians Llc. | 0244413391 | 619 |
News Archive
Lucile Packard Children's Hospital and Stanford Hospital & Clinics announce that the hospitals have reached a new contract agreement with employees represented by the SEIU United Healthcare Workers West (SEIU-UHW) union. The SEIU-UHW membership, which represents 1,450 out of 9,172 employees at the hospitals in jobs such as housekeeping, food service, nursing assistants, and technicians, ratified the contract in a vote Thursday, August 27.
Pierre Fabre Dermatologie has obtained marketing authorization from the FDA for the pediatric drug Hemangeol (propranolol hydrochloride), which is the first and only approved treatment for "proliferating infantile hemangioma requiring systemic therapy".
Medtronic, Inc. announced today pivotal data for the Medtronic Arctic Front® CryoAblation Catheter System will be presented as a late breaking clinical trial at the 59th Annual Scientific Session of the American College of Cardiology on Monday, March 15 at 8 a.m. ET. The STOP-AF (Sustained Treatment of Paroxysmal Atrial Fibrillation) clinical trial is evaluating the safety and efficacy of the Arctic Front CryoAblation Catheter System for paroxysmal atrial fibrillation (AF) patients.
Like the shape-shifting robots of "Transformers" fame, a unique class of proteins in the human body also has the ability to alter their configuration. These so-named intrinsically disordered proteins (IDPs) lack a fixed or ordered three-dimensional structure, which can be influenced by exposure to various chemicals and cellular modifications.
› Verified 4 days ago
Entity Name | Affinity Physicians Llc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1184944662 PECOS PAC ID: 0244413391 Enrollment ID: O20110326000053 |
News Archive
Lucile Packard Children's Hospital and Stanford Hospital & Clinics announce that the hospitals have reached a new contract agreement with employees represented by the SEIU United Healthcare Workers West (SEIU-UHW) union. The SEIU-UHW membership, which represents 1,450 out of 9,172 employees at the hospitals in jobs such as housekeeping, food service, nursing assistants, and technicians, ratified the contract in a vote Thursday, August 27.
Pierre Fabre Dermatologie has obtained marketing authorization from the FDA for the pediatric drug Hemangeol (propranolol hydrochloride), which is the first and only approved treatment for "proliferating infantile hemangioma requiring systemic therapy".
Medtronic, Inc. announced today pivotal data for the Medtronic Arctic Front® CryoAblation Catheter System will be presented as a late breaking clinical trial at the 59th Annual Scientific Session of the American College of Cardiology on Monday, March 15 at 8 a.m. ET. The STOP-AF (Sustained Treatment of Paroxysmal Atrial Fibrillation) clinical trial is evaluating the safety and efficacy of the Arctic Front CryoAblation Catheter System for paroxysmal atrial fibrillation (AF) patients.
Like the shape-shifting robots of "Transformers" fame, a unique class of proteins in the human body also has the ability to alter their configuration. These so-named intrinsically disordered proteins (IDPs) lack a fixed or ordered three-dimensional structure, which can be influenced by exposure to various chemicals and cellular modifications.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Isha Shah, MD 111 Brewster St, Pawtucket, RI 02860-4474 Ph: (401) 729-2258 | Isha Shah, MD 455 Toll Gate Rd, Warwick, RI 02886-2759 Ph: (401) 681-2858 |
News Archive
Lucile Packard Children's Hospital and Stanford Hospital & Clinics announce that the hospitals have reached a new contract agreement with employees represented by the SEIU United Healthcare Workers West (SEIU-UHW) union. The SEIU-UHW membership, which represents 1,450 out of 9,172 employees at the hospitals in jobs such as housekeeping, food service, nursing assistants, and technicians, ratified the contract in a vote Thursday, August 27.
Pierre Fabre Dermatologie has obtained marketing authorization from the FDA for the pediatric drug Hemangeol (propranolol hydrochloride), which is the first and only approved treatment for "proliferating infantile hemangioma requiring systemic therapy".
Medtronic, Inc. announced today pivotal data for the Medtronic Arctic Front® CryoAblation Catheter System will be presented as a late breaking clinical trial at the 59th Annual Scientific Session of the American College of Cardiology on Monday, March 15 at 8 a.m. ET. The STOP-AF (Sustained Treatment of Paroxysmal Atrial Fibrillation) clinical trial is evaluating the safety and efficacy of the Arctic Front CryoAblation Catheter System for paroxysmal atrial fibrillation (AF) patients.
Like the shape-shifting robots of "Transformers" fame, a unique class of proteins in the human body also has the ability to alter their configuration. These so-named intrinsically disordered proteins (IDPs) lack a fixed or ordered three-dimensional structure, which can be influenced by exposure to various chemicals and cellular modifications.
› Verified 4 days ago
Dr. Sterling Leaf Malish, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 455 Toll Gate Rd, Warwick, RI 02886 Phone: 401-737-7000 | |
Dr. John David Lowney, Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1030 Warwick Ave, Warwick, RI 02888 Phone: 401-467-6257 Fax: 401-785-1191 | |
Dr. Christian Rene Herard, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 300 Tollgate Road, Suite 302, Warwick, RI 02886 Phone: 401-738-4014 Fax: 401-738-4090 | |
John A Gelzhiser, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 455 Toll Gate Rd, Warwick, RI 02886 Phone: 401-737-7000 Fax: 401-736-4265 | |
Dr. Michael Seidler, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 125 Metro Center Blvd Ste 2000, Warwick, RI 02886 Phone: 401-921-9202 Fax: 401-921-9212 | |
Murli K Raman, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 455 Tollgate Rd, Brigham & Women's Cardiovascular Associates At Cne, Warwick, RI 02886 Phone: 401-681-4996 Fax: 401-921-6569 | |
Dr. Jennifer F Jarbeau, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 400 Bald Hill Rd Ste 524, Warwick, RI 02886 Phone: 401-737-7313 Fax: 401-737-4207 |